AMLX vs FMC · $561.6M cap vs rev $1.63B
Amylyx Pharmaceuticals Inc (AMLX) versus FMC Corporation (FMC) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
Latest reported FMC revenue for 2026-06-30 was $1.63B. Net income was -$467.9M. FMC currently screens at market cap $1.50B.
AMLX currently screens at market cap $561.6M. FMC currently screens at market cap $1.50B.
Not investment advice. Open the AMLX and FMC stock pages for the full models.
Not investment advice.